Section Arrow
INVA.NASDAQ
- Innoviva
Quotes are at least 15-min delayed:2025/01/11 17:08 EST
Last
 17.28
-0.03 (-0.17%)
Day High 
17.295 
Prev. Close
17.31 
1-M High
19.23 
Volume 
435.92K 
Bid
17.28
Ask
17.29
Day Low
17.12 
Open
17.13 
1-M Low
17.01 
Market Cap 
1.08B 
Currency USD 
P/E 21.64 
%Yield 1.45 
10-SMA 17.46 
20-SMA 17.89 
50-SMA 18.79 
52-W High 21.28 
52-W Low 14.325 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.80/2.24
Enterprise Value
1.53B
Balance Sheet
Book Value Per Share
10.68
Cash Flow
Cash Flow Yield
0.14
Income Statement
Total Revenue
310.46M
Operating Revenue Per Share
4.64
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CDTConduit Pharmaceuticals0.1233+0.0413+50.37%-- 
MRSNMersana Therapeutics0.72-0.58-44.62%-- 
TNXPTonix Pharmaceuticals Holding Corp.0.2787+0.0227+8.87%-- 
ZVSAZyVersa Therapeutics1.47+0.29+24.58%0PE
SANASana Biotechnology3.66-0.64-14.88%-- 
Quotes are at least 15-min delayed:2025/01/11 17:08 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.